Prostate Cancer News and Research

Latest Prostate Cancer News and Research

Theragenics signs supply agreement with Oncura for TheraSeed palladium-103 brachytherapy seeds

Theragenics signs supply agreement with Oncura for TheraSeed palladium-103 brachytherapy seeds

Common SNP in sequence of human genome conferring risk of vascular diseases discovered

Common SNP in sequence of human genome conferring risk of vascular diseases discovered

Midatech, Immunotope form joint venture to develop antigen based products for immune therapies

Midatech, Immunotope form joint venture to develop antigen based products for immune therapies

Oklahoma City ProCure Proton Therapy Center celebrates first-year anniversary

Oklahoma City ProCure Proton Therapy Center celebrates first-year anniversary

Men with higher baseline PSA value more likely to die from prostate cancer, say researchers

Men with higher baseline PSA value more likely to die from prostate cancer, say researchers

Overall cancer mortality rates continue to decrease, new report shows

Overall cancer mortality rates continue to decrease, new report shows

Northwest Biotherapeutics raises $2.65M during second-quarter

Northwest Biotherapeutics raises $2.65M during second-quarter

Patients are not presented with information about prostate cancer treatment options: Urologists

Patients are not presented with information about prostate cancer treatment options: Urologists

Study finds additional targets for new therapies to treat advanced prostate cancer patients

Study finds additional targets for new therapies to treat advanced prostate cancer patients

VA addresses health concerns including possible HIV exposure and Veterans' general poor health

VA addresses health concerns including possible HIV exposure and Veterans' general poor health

EUSA grants Ohara Japanese rights to Erwinase oncology therapy

EUSA grants Ohara Japanese rights to Erwinase oncology therapy

64-year-old female Latin American receives Elekta VMAT radiotherapy enhanced with Monaco planning software

64-year-old female Latin American receives Elekta VMAT radiotherapy enhanced with Monaco planning software

ZERO demands ACS apology on effectiveness of PSA test

ZERO demands ACS apology on effectiveness of PSA test

Endo subsidiary successfully completes tender offer for HealthTronics' outstanding common stock

Endo subsidiary successfully completes tender offer for HealthTronics' outstanding common stock

Modified Citrus Pectin holds promise against prostate cancer

Modified Citrus Pectin holds promise against prostate cancer

Researchers develop first model of hormone-induced human prostate cancer initiation and progression

Researchers develop first model of hormone-induced human prostate cancer initiation and progression

Medicare weighs cost, benefit of covering Dendreon's Provenge for prostate cancer

Medicare weighs cost, benefit of covering Dendreon's Provenge for prostate cancer

Advanced Cancer Therapeutics secures $10M in investments

Advanced Cancer Therapeutics secures $10M in investments

Highly specific assay developed to detect ERG alterations in prostate cancer

Highly specific assay developed to detect ERG alterations in prostate cancer

Endo responds to FDA Complete Response letter for FORTESTA NDA

Endo responds to FDA Complete Response letter for FORTESTA NDA

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.